Dr. Plimack on Strategies for Developing Cure for Locally Advanced Urothelial Carcinoma

Elizabeth Plimack, MD
Published: Thursday, Sep 28, 2017



Elizabeth Plimack, MD, director of Genitourinary Clinical Research at Fox Chase Cancer Center, discusses strategies for developing cures for patients with locally advanced urothelial carcinoma.

Locally advanced bladder cancer has made its way into the muscle of the bladder but hasn’t extended beyond that, explains Plimack. It is a high-risk situation where, if left untreated, many patients would progress to metastatic disease. It also presents an opportunity for cure and many researchers are developing the best strategies to increase the cure rate for these patients.

Neoadjuvant cisplatin-based chemotherapy is proven to improve the cure rate and extend survival in this group, states Plimack. However, there is ongoing biomarker research that is looking to see which patients will benefit the most and can keep their bladder.
 
SELECTED
LANGUAGE


Elizabeth Plimack, MD, director of Genitourinary Clinical Research at Fox Chase Cancer Center, discusses strategies for developing cures for patients with locally advanced urothelial carcinoma.

Locally advanced bladder cancer has made its way into the muscle of the bladder but hasn’t extended beyond that, explains Plimack. It is a high-risk situation where, if left untreated, many patients would progress to metastatic disease. It also presents an opportunity for cure and many researchers are developing the best strategies to increase the cure rate for these patients.

Neoadjuvant cisplatin-based chemotherapy is proven to improve the cure rate and extend survival in this group, states Plimack. However, there is ongoing biomarker research that is looking to see which patients will benefit the most and can keep their bladder.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication
x